RENOVORX, INC. Debt Securities, Available-for-sale, Unrealized Loss
RENOVORX, INC. (RNXT) reported Debt Securities, Available-for-sale, Unrealized Loss of $4.00 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2022-08-12
- 2022-06-30: Debt Securities, Available-for-sale, Unrealized Loss 6 month $4.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 6 month |
|---|---|
| 2022-06-30 | $4.00K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |